Historical record - last NADAC publication: 5/23/2013

Product Information

CEFPODOXIME 100 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $1.2492 per ML under NDC 65862014150. Its NADAC has been published 29 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Cefpodoxime Proxetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CEFPODOXIME 100 MG/5 ML SUSP

Cefpodoxime Proxetil
$1.2492per ML
High Outlier

Strength

100 mg/5mL

NDC

65862014150

Classification

Generic

Dosage Form

GRANULE, FOR SUSPENSION

Route

ORAL

Last Updated

5/23/2013

Active Ingredients

CEFPODOXIME PROXETIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065409

On Market Since

6/8/2007

Pharmacological Classes

Price Statistics

The NADAC for CEFPODOXIME 100 MG/5 ML SUSP has been published 29 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.2492 per ML
All-time high$1.2492 (Jun 11, 2014)
All-time low$1.2492 (Nov 28, 2013)
Median price$1.2492
Average price$1.2492
Largest weekly change0.0% (Dec 5, 2013)
Weeks tracked29
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

0.0%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CEFPODOXIME 100 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFPODOXIME 100 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $1.2492 per ML (NDC 65862014150), effective Jun 11, 2014.

How has the price of CEFPODOXIME 100 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFPODOXIME 100 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 29 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEFPODOXIME 100 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for CEFPODOXIME 100 MG/5 ML SUSP has ranged from a low of $1.2492 (Nov 28, 2013) to a high of $1.2492 (Jun 11, 2014), with a median of $1.2492 per ML.

Are there cheaper alternatives to CEFPODOXIME 100 MG/5 ML SUSP?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CEFPODOXIME 100 MG/5 ML SUSP, is $1.0449 per ML — about 16% below CEFPODOXIME 100 MG/5 ML SUSP.

Who manufactures CEFPODOXIME 100 MG/5 ML SUSP?

CEFPODOXIME 100 MG/5 ML SUSP (NDC 65862014150) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.